Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia | Zendy

Christoph U. Correll | Zendy; José M. Rubio | Zendy; Gabriella Inczédy-Farkas | Zendy; Michael L. Birnbaum | Zendy; John M. Kane | Zendy; Stefan Leucht | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia

Author(s) -

Christoph U. Correll,

José M. Rubio,

Gabriella Inczédy-Farkas,

Michael L. Birnbaum,

John M. Kane,

Stefan Leucht

Publication year - 2017

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2017.0624

Subject(s) - antipsychotic , clozapine , discontinuation , schizophrenia (object oriented programming) , medicine , randomized controlled trial , olanzapine , strictly standardized mean difference , meta analysis , psychiatry , typical antipsychotic , amisulpride , atypical antipsychotic , psychology

Limited treatment responses in schizophrenia prompted the testing of combining an antipsychotic drug treatment with a second psychotropic medication. A comprehensive evaluation of the efficacy of multiple medication combinations is missing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research